Abaloparatide is a parathyroid hormone-related protein (PTHrP) analog drug used to treat osteoporosis.
This report contains market size and forecasts of Abaloparatide API in global, including the following market information:
Global Abaloparatide API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Abaloparatide API Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Abaloparatide API companies in 2021 (%)
The global Abaloparatide API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
?99.0% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Abaloparatide API include Sun Pharmaceutical Industries Ltd., Dr. Reddys Laboratories Ltd., Aprazer Healthcare Private Limited, Hangzhou Huarong Pharm Co., Ltd., Teva Pharmaceutical Industries, Apicore LLC, Conscientia Industrial Co., Ltd and CCSB, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Abaloparatide API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Abaloparatide API Market, by Purity, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Abaloparatide API Market Segment Percentages, by Purity, 2021 (%)
Global Abaloparatide API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Abaloparatide API Market Segment Percentages, by Application, 2021 (%)
Global Abaloparatide API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Abaloparatide API Market Segment Percentages, By Region and Country, 2021 (%)
Rest of Europe
Rest of Asia
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Abaloparatide API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Abaloparatide API revenues share in global market, 2021 (%)
Key companies Abaloparatide API sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Abaloparatide API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sun Pharmaceutical Industries Ltd.
Dr. Reddys Laboratories Ltd.
Aprazer Healthcare Private Limited
Hangzhou Huarong Pharm Co., Ltd.
Teva Pharmaceutical Industries
Conscientia Industrial Co., Ltd
Table of content
1 Introduction to Research & Analysis Reports
1.1 Abaloparatide API Market Definition
1.2 Market Segments
1.2.1 Market by Purity
1.2.2 Market by Application
1.3 Global Abaloparatide API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Abaloparatide API Overall Market Size
2.1 Global Abaloparatide API Market Size: 2021 VS 2028
2.2 Global Abaloparatide API Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Abaloparatide API Sales: 2017-2028
3 Company Landscape
3.1 Top Abaloparatide API Players in Global Market
3.2 Top Global Abaloparatide API Companies Ranked by Revenue
3.3 Global Abaloparatide API Revenue by Companies
3.4 Global Abaloparatide API Sales by Companies
3.5 Global Abaloparatide API Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Abaloparatide API Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Abaloparatide API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Abaloparatide API Players in Global Market
3.8.1 List of Global Tier 1 Abaloparatide API Companies
3.8.2 List of Global Tier 2 and Tier 3 Abaloparatide API Companies
4 Sights by Product
4.1.1 By Purity – Global Abaloparatide API Market Size Markets, 20
North Main Road Koregaon Park, Pune, India – 411001.
Asia: +91 9169162030